SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment

By
lbeveridge
-
0
113
Investigators discuss the role of SHP2 in cancer and the tumor microenvironment, and the clinical strategies in which SHP2 inhibitors are leveraged as combination agents to improve therapeutic response.
[Cancer Discovery]
Abstract